BioVie, Inc. (BIVI)

NASDAQ: BIVI · IEX Real-Time Price · USD
2.57
0.03 (1.18%)
May 27, 2022 3:59 PM EDT - Market closed

Total Valuation

BioVie has a market cap or net worth of $64.21 million. The enterprise value is $51.45 million.

Market Cap64.21M
Enterprise Value51.45M

Important Dates

Earnings Daten/a
Ex-Dividend Daten/a

Share Statistics

BioVie has 24.98 million shares outstanding. The number of shares has increased by 79.48% in one year.

Shares Outstanding24.98M
Shares Change (YoY)+79.48%
Shares Change (QoQ)+0.09%
Owned by Insiders (%)79.74%
Owned by Institutions (%)6.28%
Float5.13M

Valuation Ratios

PE Ration/a
Forward PEn/a
PS Ration/a
PB Ratio6.45
P/FCF Ration/a
PEG Ration/a
Financial Ratio History

Enterprise Valuation

EV / Earningsn/a
EV / Salesn/a
EV / EBITDAn/a
EV / EBITn/a
EV / FCFn/a

Financial Position

The company has a current ratio of 5.74, with a Debt / Equity ratio of 1.18.

Current Ratio5.74
Quick Ratio5.68
Debt / Equity1.18
Debt / EBITDAn/a
Debt / FCFn/a

Financial Efficiency

Return on equity (ROE) is -1,165.80%, which is considered low. The company has a ROIC of -4,671.60%.

Return on Equity (ROE)-1,165.80%
Return on Assets (ROA)-694.80%
Return on Capital (ROIC)-4,671.60%
Revenue Per Employeen/a
Profits Per Employee-$24.92M
Employee Count6
Asset Turnovern/a
Inventory Turnovern/a

Taxes

Income Taxn/a
Effective Tax Raten/a

Stock Price Statistics

The stock price has decreased by -82.54% in the last 52 weeks. The beta is 2.26, so BioVie's price volatility has been higher than the market average.

Beta (1Y)2.26
52-Week Price Change-82.54%
50-Day Moving Average3.51
200-Day Moving Average4.18
Average Volume (30 Days)38,431

Short Selling Information

The latest short interest is 121,731, so 0.49% of the outstanding shares have been sold short.

Short Interest121,731
Short % of Shares Out0.49%
Short % of Float2.37%
Short Ratio (days to cover)2.58

Income Statement

Revenuen/a
Gross Profitn/a
Operating Income-149.56M
Net Income-149.53M
EBITDA-148.06M
EBIT-148.29M
Earnings Per Share (EPS)-$6.69
Full Income Statement

Balance Sheet

The company has $24.51 million in cash and $11.75 million in debt, giving a net cash position of $12.75 million or $0.51 per share.

Cash & Cash Equivalents24.51M
Total Debt11.75M
Net Cash12.75M
Net Cash Per Share$0.51
Book Value9.95M
Book Value Per Share0.40
Working Capital20.47M
Full Balance Sheet

Cash Flow

Operating Cash Flow-20.13M
Capital Expendituresn/a
Free Cash Flow-20.13M
FCF Per Sharen/a
Full Cash Flow Statement

Margins

Gross Marginn/a
Operating Marginn/a
Pretax Marginn/a
Profit Marginn/a
EBITDA Marginn/a
EBIT Marginn/a
FCF Marginn/a

Dividends & Yields

BioVie does not appear to pay any dividends at this time.

Dividend Per Sharen/a
Dividend Yieldn/a
Earnings Yield-232.88%
FCF Yield-31.36%
Dividend Growth (YoY)n/a
Payout Ration/a
Buyback Yield-79.48%
Shareholder Yield-79.48%
Dividend Details

Analyst Forecast

The average price target for BioVie is $13.94, which is 442.41% higher than the current price. The consensus rating is "Buy".

Price Target$13.94
Price Target Difference442.41%
Analyst ConsensusBuy
Analyst Count9
Stock Forecasts

Stock Splits

The last stock split was on November 22, 2019. It was a reverse split with a ratio of 1:125.

Last Split DateNov 22, 2019
Split TypeReverse
Split Ratio1:125